Provided by Tiger Trade Technology Pte. Ltd.

JACOBIO-B

6.300
-0.275-4.18%
Volume:11.87M
Turnover:73.79M
Market Cap:4.93B
PE:-28.64
High:6.550
Open:6.550
Low:5.915
Close:6.575
52wk High:11.800
52wk Low:3.980
Shares:782.00M
HK Float Shares:782.00M
Volume Ratio:2.15
T/O Rate:1.52%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.220
ROE:46.30%
ROA:20.59%
PB:3.12
PE(LYR):-28.65
PS:5.72

Loading ...

Jacobio Pharmaceuticals files HKEX next-day disclosure return for share repurchase at HKD 6.68 per share

Reuters
·
Mar 20

JACOBIO-B (01167) Buys Back 150,000 Shares; Treasury Stock Rises to 5.56 Million

Bulletin Express
·
Mar 19

Jacobio-B Allocates HK$1.013 Million for Share Buyback on March 19

Stock News
·
Mar 19

Jacobio Pharmaceuticals files HKEX next-day disclosure return reporting HKD 6.75 per-share buyback

Reuters
·
Mar 19

JACOBIO-B (01167) Repurchases 144,000 Shares for HK$0.998 Million; Total Treasury Stock Reaches 5.41 Million

Bulletin Express
·
Mar 18

Jacobio-B (01167) Allocates HK$998,000 for Share Buyback on March 18

Stock News
·
Mar 18

JACOBIO-B (01167) Buys Back 144,000 Shares; Treasury Stock Climbs to 5.27 Million

Bulletin Express
·
Mar 17

CMB International Foresees Accelerated Fundamental Improvement in China's Healthcare Sector, Recommends Buying Innovent Bio, 3SBIO, and Others

Stock News
·
Mar 17

JACOBIO-B Spends HK$274,000 on Share Buyback on March 16

Stock News
·
Mar 16

Jacobio Pharmaceuticals files HKEX next-day disclosure return on share repurchase at HKD 7.03 per share

Reuters
·
Mar 16

Jacobio-B Shares Climb Over 6% Following Earnings Report, Highlights Multiple R&D Breakthroughs in 2025 and Collaboration with AstraZeneca on JAB-23E73

Stock News
·
Mar 11

Stock Track | JACOBIO-B Soars 5.35% Intraday on Strong 2025 Results, AstraZeneca Collaboration and Positive Pan-KRAS Clinical Data

Stock Track
·
Mar 11

New Variable in Pan-KRAS Space: Valuation Gap Behind JAB-23E73's 38.5% ORR in Pancreatic Cancer

Stock News
·
Mar 11

Jacobio reports 2025 results as glecirasib revenue reaches CNY 8.55 million

Reuters
·
Mar 10

Jacobio Announces 2025 Annual Results

THOMSON REUTERS
·
Mar 10

Jacobio Pharmaceuticals - Anticipates Achieving Profitability in 2026

THOMSON REUTERS
·
Mar 10

JACOBIO-B (01167) Achieves Multiple R&D Pipeline Breakthroughs in 2025, Accelerates Global Strategy, and Narrows Net Loss

Stock News
·
Mar 10

Jacobio-B (01167) FY2025: Loss Narrows to RMB146 Million as R&D Spend Falls 42.9%; Glecirasib Launch, Pan-KRAS Deal with AstraZeneca Highlight Pipeline Progress

Bulletin Express
·
Mar 10

Jacobio Pharmaceuticals FY2025 revenue fell 66% to CNY53.53 million

Reuters
·
Mar 10

Jacobio Pharmaceuticals Group FY Revenue RMB 53.5 Million

THOMSON REUTERS
·
Mar 10